首页 > 最新文献

Epilepsy Research最新文献

英文 中文
High density probes reveal medullary seizure and rapid medullary shutdown in a model of fatal apnea in seizure 高密度探针显示致命呼吸暂停发作模型中的髓质发作和髓质快速关闭
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-08-21 DOI: 10.1016/j.eplepsyres.2025.107642
Ryan Budde , Laura RoaFiore , Pedro Irazoqui
Objective: Sudden unexpected death in epilepsy (SUDEP) is suggested to be a cardiorespiratory collapse that occurs shortly after a seizure. The impacts of seizure on medullary respiratory control remain poorly understood. Prior work in rats suggests that reflexive apneas are highly fatal during seizure but well tolerated otherwise. These reflexes share network connectivity in the medulla, particularly the caudal solitary nucleus (NTS) and ventral respiratory column (VRC), and possibly other intermediate structures. We sought to observe the activity in these regions in fatal ictal apneas. Methods: We collected data from urethane anesthetized long evans rats. To record neural activity we used either 125 µm silver wire in the caudal NTS or a Neuropixel 1.0 probe along a dorsoventral trajectory that spanned the caudal NTS to the VRC. We additionally recorded cardiorespiratory activity via several methods. We induced a reflexive apnea – the diving reflex – by nasal irrigation of cold water for several seconds, which produces a period of apnea, then gasping, and then a gradual return to eupnea. We repeated several trials while the animal was healthy and subsequently induced continuous seizure activity with kainate and repeated the reflexes, which are ultimately fatal during seizure. Results: Seizure activity confounds many established methods of analyzing high-density single unit data such as provided by Neuropixels probes, and so our analyses focus on averaging responses over larger anatomical regions (120 µm) covering small populations of neurons. Seizure produces broad increases in neuronal activity across the medullary tract, which by itself is not dangerous. Ictal reflexive apneas were broadly more inhibitory (producing a reduction in firing rate) than they were preictally, and fatal ictal responses resulted in a very rapid shutdown of all medullary activity. We only rarely observed ictal central apneas (apneas with no apparent stimuli), but when we did they were apparently safe, always survived, and produced no significant change in network activity (neither increase nor decrease). Conclusions: These data support the theory that central apnea events in seizure are relatively safe as we observed they produce little change in the medullary tract network, while stimuli-induced-reflexive-apneas are dangerous because they produce profound quieting across respiratory centers. Our data suggest that seizure spreads to this medullary tract at approximately the same rate and intensity as forebrain, as previously described in this model. These data are supportive of SUDEP mechanisms involving brainstem inhibition as a primary cause, such as spreading depolarization waves. These findings likely extend beyond nasal irrigation to any sensory reflexive apnea caused by airway irritation of any kind, and may bear relevance to similar deaths seen in infants.
目的:癫痫猝死(SUDEP)被认为是癫痫发作后不久发生的心肺衰竭。癫痫发作对髓质呼吸控制的影响仍然知之甚少。先前对大鼠的研究表明,反身性呼吸暂停在癫痫发作期间是高度致命的,但在其他情况下耐受性良好。这些反射在髓质,特别是尾侧孤立核(NTS)和腹侧呼吸柱(VRC),以及可能的其他中间结构中共享网络连接。我们试图观察致死性呼吸暂停时这些区域的活动。方法:收集聚氨酯麻醉的长evans大鼠的数据。为了记录神经活动,我们在尾侧NTS中使用125 µm的银线,或者沿着背侧轨迹沿着横跨尾侧NTS到VRC的Neuropixel 1.0探针。我们还通过几种方法记录了心肺活动。我们用冷水鼻腔冲洗几秒钟,诱导反射性呼吸暂停——潜水反射,这产生一段时间的呼吸暂停,然后喘气,然后逐渐恢复到呼吸暂停。我们在动物健康的情况下重复了几次试验,随后用kainate诱导了持续的癫痫发作活动,并重复了最终在癫痫发作期间致命的反射。结果:癫痫活动混淆了许多已建立的分析高密度单单元数据的方法,例如由Neuropixels探针提供的数据,因此我们的分析重点是在覆盖小群体神经元的较大解剖区域(120 µm)上平均反应。癫痫发作会使整个髓束的神经元活动广泛增加,这本身并不危险。发作性反射性呼吸暂停比预期更具有抑制作用(产生放电率降低),致命的发作性反应导致所有髓质活动非常迅速地停止。我们很少观察到中枢呼吸暂停(没有明显刺激的呼吸暂停),但当我们这样做时,它们显然是安全的,总是存活下来,并且网络活动没有显著变化(既没有增加也没有减少)。结论:这些数据支持这样的理论,即癫痫发作时的中枢性呼吸暂停事件相对安全,因为我们观察到它们在髓束网络中产生很少的变化,而刺激诱导的反射性呼吸暂停是危险的,因为它们在呼吸中枢产生深度平静。我们的数据表明,癫痫发作以与前脑大致相同的速度和强度扩散到这个髓束,正如之前在这个模型中所描述的那样。这些数据支持涉及脑干抑制作为主要原因的猝死机制,如扩散去极化波。这些发现可能不仅适用于鼻腔冲洗,也适用于由任何类型的气道刺激引起的任何感觉反射性呼吸暂停,并且可能与在婴儿中看到的类似死亡有关。
{"title":"High density probes reveal medullary seizure and rapid medullary shutdown in a model of fatal apnea in seizure","authors":"Ryan Budde ,&nbsp;Laura RoaFiore ,&nbsp;Pedro Irazoqui","doi":"10.1016/j.eplepsyres.2025.107642","DOIUrl":"10.1016/j.eplepsyres.2025.107642","url":null,"abstract":"<div><div>Objective: Sudden unexpected death in epilepsy (SUDEP) is suggested to be a cardiorespiratory collapse that occurs shortly after a seizure. The impacts of seizure on medullary respiratory control remain poorly understood. Prior work in rats suggests that reflexive apneas are highly fatal during seizure but well tolerated otherwise. These reflexes share network connectivity in the medulla, particularly the caudal solitary nucleus (NTS) and ventral respiratory column (VRC), and possibly other intermediate structures. We sought to observe the activity in these regions in fatal ictal apneas. Methods: We collected data from urethane anesthetized long evans rats. To record neural activity we used either 125 <em>µ</em>m silver wire in the caudal NTS or a Neuropixel 1.0 probe along a dorsoventral trajectory that spanned the caudal NTS to the VRC. We additionally recorded cardiorespiratory activity via several methods. We induced a reflexive apnea – the diving reflex – by nasal irrigation of cold water for several seconds, which produces a period of apnea, then gasping, and then a gradual return to eupnea. We repeated several trials while the animal was healthy and subsequently induced continuous seizure activity with kainate and repeated the reflexes, which are ultimately fatal during seizure. Results: Seizure activity confounds many established methods of analyzing high-density single unit data such as provided by Neuropixels probes, and so our analyses focus on averaging responses over larger anatomical regions (120 <em>µ</em>m) covering small populations of neurons. Seizure produces broad increases in neuronal activity across the medullary tract, which by itself is not dangerous. Ictal reflexive apneas were broadly more inhibitory (producing a reduction in firing rate) than they were preictally, and fatal ictal responses resulted in a very rapid shutdown of all medullary activity. We only rarely observed ictal central apneas (apneas with no apparent stimuli), but when we did they were apparently safe, always survived, and produced no significant change in network activity (neither increase nor decrease). Conclusions: These data support the theory that central apnea events in seizure are relatively safe as we observed they produce little change in the medullary tract network, while stimuli-induced-reflexive-apneas are dangerous because they produce profound quieting across respiratory centers. Our data suggest that seizure spreads to this medullary tract at approximately the same rate and intensity as forebrain, as previously described in this model. These data are supportive of SUDEP mechanisms involving brainstem inhibition as a primary cause, such as spreading depolarization waves. These findings likely extend beyond nasal irrigation to any sensory reflexive apnea caused by airway irritation of any kind, and may bear relevance to similar deaths seen in infants.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"218 ","pages":"Article 107642"},"PeriodicalIF":2.0,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144890017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Co-morbid seizures in frontotemporal dementia: What do they tell us? 额颞叶痴呆的共病性癫痫发作:它们告诉我们什么?
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-08-13 DOI: 10.1016/j.eplepsyres.2025.107640
Syeda Amrah Hashmi , Mark Quigg , Anelyssa D’Abreu , Carol Manning , Jaideep Kapur , Ifrah Zawar

Objectives

Comorbid seizures occur in 2–11 % of frontotemporal dementia(FTD). Despite the high risk for seizures, the risk factors, clinical characteristics, and seizure outcomes in FTD patients with comorbid seizures remain understudied.

Methods

All patients who presented to our hospital from 5/1/2011–4/30/2024 with a clinical diagnosis of FTD were included and subclassified into behavioral-variant FTD(bvFTD), sematic-variant-primary-progressive-aphasia(svPPA), or non-fluent-primary-progressive-aphasia(nfPPA). Demographics, comorbidities, dementia characteristics, and seizure characteristics were obtained from electronic medical records. Patients were classified into those with(FTD+SZ) or without(FTD-SZ) clinically-diagnosed seizures. Seizure outcome was categorized as uncontrolled, controlled on anti-seizure-medications(ASMs), or self-resolving if resolved without ASMs. Data were analyzed using Pearson’s Chi-squared, Fisher Exact, or t-tests.

Results

Of 317 FTD patients(average age of dementia onset=64.18+9.07years,46.37 % female]), 24(7.6 %) reported seizures. FTD+SZ were more likely to have anxiety(FTD+SZ=7(29.17 %),FTD-SZ= 35(11.95 %),p = 0.0392).Traumatic brain injury(TBI) was the only risk factor for seizures(FTD+SZ=6(25 %),FTD-SZ= 18(6 %),p < 0.001). BvFTD was the most common subtype in FTD+SZ(54.17 %). Focal seizures were more common(50 %) than generalized (29.17 %), with temporal-lobe epilepsy(TLE) being the most common subtype of focal seizures(42 %). Levetiracetam was the most frequently used ASM(38.1 %). Seizures had a favorable prognosis, with 87.5 % achieving seizure control through ASMs, and seizures self-resolving in the rest. FTD+SZ were more likely to be older at death(FTD+SZ=78.63years,FTD-SZ=71.37,p = 0.03966).

Significance

The prevalence of comorbid seizures in FTD at our single-center is 7.6 %. They were most common in bvFTD, primarily focal, with TLE as the predominant subtype. Anxiety was more prevalent with comorbid seizures. Most achieved seizure control on ASMs. FTD+SZ were older at death. These findings address a critical gap, guiding diagnosis, management, and future research.
目的:在额颞叶痴呆(FTD)患者中,2 - 11% %发生癫痫共病。尽管癫痫发作的风险很高,但合并癫痫发作的FTD患者的危险因素、临床特征和癫痫结局仍未得到充分研究。方法纳入2011年5月1日至2024年4月30日期间所有临床诊断为FTD的患者,并将其分为行为变异性FTD(bvFTD)、语义变异性原发进行性失语症(svPPA)和非流利性原发进行性失语症(nfPPA)。统计数据、合并症、痴呆特征和癫痫发作特征从电子病历中获得。患者被分为有(FTD+SZ)和没有(FTD-SZ)临床诊断癫痫发作。癫痫发作结果分为不受控制,抗癫痫药物(asm)控制,或自行解决(如果没有asm)。数据分析采用皮尔逊卡方检验、Fisher精确检验或t检验。结果317例FTD患者(平均痴呆发病年龄64.18+9.07岁,女性46.37 %)中,24例(7.6 %)报告癫痫发作。FTD+SZ更容易出现焦虑(FTD+SZ=7(29.17 %),FTD-SZ= 35(11.95 %),p = 0.0392)。创伤性脑损伤(TBI)是癫痫发作的唯一危险因素(FTD+SZ=6(25 %),FTD-SZ= 18(6 %),p <; 0.001)。BvFTD是FTD+SZ中最常见的亚型(54.17 %)。局灶性癫痫发作(50 %)比全面性癫痫发作(29.17 %)更为常见,其中颞叶癫痫(TLE)是最常见的局灶性癫痫发作亚型(42 %)。左乙拉西坦是最常用的ASM(38.1 %)。癫痫发作预后良好,87.5% %的患者通过抗痉挛药物获得癫痫发作控制,其余患者癫痫发作自行消退。FTD+SZ组死亡年龄更大(FTD+SZ=78.63岁,FTD-SZ=71.37,p = 0.03966)。意义:在我们的单中心研究中,FTD共病性癫痫的患病率为7.6% %。它们在bvFTD中最常见,主要是局灶性的,以TLE为主要亚型。焦虑在共病发作中更为普遍。大多数患者在抗痉挛药物治疗中获得了癫痫控制。FTD+SZ在死亡时年龄较大。这些发现解决了一个关键的差距,指导诊断、管理和未来的研究。
{"title":"Co-morbid seizures in frontotemporal dementia: What do they tell us?","authors":"Syeda Amrah Hashmi ,&nbsp;Mark Quigg ,&nbsp;Anelyssa D’Abreu ,&nbsp;Carol Manning ,&nbsp;Jaideep Kapur ,&nbsp;Ifrah Zawar","doi":"10.1016/j.eplepsyres.2025.107640","DOIUrl":"10.1016/j.eplepsyres.2025.107640","url":null,"abstract":"<div><h3>Objectives</h3><div>Comorbid seizures occur in 2–11 % of frontotemporal dementia(FTD). Despite the high risk for seizures, the risk factors, clinical characteristics, and seizure outcomes in FTD patients with comorbid seizures remain understudied.</div></div><div><h3>Methods</h3><div>All patients who presented to our hospital from 5/1/2011–4/30/2024 with a clinical diagnosis of FTD were included and subclassified into behavioral-variant FTD(bvFTD), sematic-variant-primary-progressive-aphasia(svPPA), or non-fluent-primary-progressive-aphasia(nfPPA). Demographics, comorbidities, dementia characteristics, and seizure characteristics were obtained from electronic medical records. Patients were classified into those with(FTD+SZ) or without(FTD-SZ) clinically-diagnosed seizures. Seizure outcome was categorized as uncontrolled, controlled on anti-seizure-medications(ASMs), or self-resolving if resolved without ASMs. Data were analyzed using Pearson’s Chi-squared, Fisher Exact, or t-tests.</div></div><div><h3>Results</h3><div>Of 317 FTD patients(average age of dementia onset=64.18<u>+</u>9.07years,46.37 % female]), 24(7.6 %) reported seizures. FTD+SZ were more likely to have anxiety(FTD+SZ=7(29.17 %),FTD-SZ= 35(11.95 %),p = 0.0392).Traumatic brain injury(TBI) was the only risk factor for seizures(FTD+SZ=6(25 %),FTD-SZ= 18(6 %),p &lt; 0.001). BvFTD was the most common subtype in FTD+SZ(54.17 %). Focal seizures were more common(50 %) than generalized (29.17 %), with temporal-lobe epilepsy(TLE) being the most common subtype of focal seizures(42 %). Levetiracetam was the most frequently used ASM(38.1 %). Seizures had a favorable prognosis, with 87.5 % achieving seizure control through ASMs, and seizures self-resolving in the rest. FTD+SZ were more likely to be older at death(FTD+SZ=78.63years,FTD-SZ=71.37,p = 0.03966).</div></div><div><h3>Significance</h3><div>The prevalence of comorbid seizures in FTD at our single-center is 7.6 %. They were most common in bvFTD, primarily focal, with TLE as the predominant subtype. Anxiety was more prevalent with comorbid seizures. Most achieved seizure control on ASMs. FTD+SZ were older at death. These findings address a critical gap, guiding diagnosis, management, and future research.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"218 ","pages":"Article 107640"},"PeriodicalIF":2.0,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144865076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health care burden of access barriers to epilepsy care in the United States: A claims-based analysis of payer channels 美国癫痫治疗可及性障碍的卫生保健负担:基于索赔的付款人渠道分析
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-08-09 DOI: 10.1016/j.eplepsyres.2025.107639
Herbert Peeples , Emily Achter , Christopher Dieyi , Keshia Maughn

Objective

To describe access challenges, barriers to antiseizure medications (ASMs), and impact of ASM formulary policies for patients with epilepsy (PWE).

Methods

Observational study of de-identified claims from an all-payer claims database (2014–2021) and a formulary/payer policy database. Adults prescribed ≥ 1 ASM following initial epilepsy diagnosis, with continuous medical/pharmacy benefits, were included. Demographic characteristics, proximity to/use of a neurology health care professional (HCP), health care resource utilization (HCRU), and costs were assessed.

Results

In total, 35,351, 33,339, and 24,722 PWE with commercial, Medicare, and Medicaid insurance, respectively, were included. The Medicare group was older, had a higher comorbidity index score, more males, and fewer non-White and Hispanic individuals versus other groups. Most (> 58 %) commercially-insured PWE had coverage to all six first-generation ASMs examined, six to 12 second-generation ASMs, and all four third-generation ASMs; coverage rates were higher for Medicaid while data for Medicare were incomplete. Most commercial and Medicaid PWE had no access requirements to first-generation ASMs; approximately two-thirds and half of patients had access requirements for second- and third-generation ASMs, respectively. Although > 90 % of PWE used a neurology HCP during follow-up, only about one-third lived within proximity. Of PWE with formulary data (N = 77,787), > 80 % and < 8.0 % were prescribed second- and third-generation ASMs, respectively. There were no clear patterns in epilepsy-related HCRU/cost.

Conclusions

Data revealed difficulties in neurologist access and predominant use of second-generation ASMs, despite access restrictions for many PWE, suggesting obstacles in accessing treatment and specialist care.
目的探讨抗癫痫药物的可及性、障碍及抗癫痫药物处方政策对癫痫患者的影响。方法对2014-2021年全付款人索赔数据库和处方/付款人政策数据库中的去识别索赔进行观察研究。纳入初始癫痫诊断后处方≥ 1 ASM的成人,并持续获得医疗/药学益处。评估了人口统计学特征、接近/使用神经内科卫生保健专业人员(HCP)、卫生保健资源利用率(HCRU)和费用。结果共纳入35,351名、33,339名、24,722名具有商业、医疗和医疗补助保险的PWE。与其他组相比,医疗保险组年龄较大,合并症指数得分较高,男性较多,非白人和西班牙裔个体较少。大多数(> 58% %)商业保险的PWE覆盖了所有6个第一代asm, 6到12个 第二代asm和所有4个第三代asm;医疗补助的覆盖率更高,而医疗保险的数据不完整。大多数商业和医疗补助PWE没有获得第一代asm的要求;大约三分之二和一半的患者分别有获得第二代和第三代asm的需求。虽然>; 90 %的PWE在随访期间使用了神经病学HCP,但只有约三分之一的人住在附近。在有公式数据的PWE中(N = 77,787),>; 80 %和<; 8.0 %分别开第二代和第三代ASMs。与癫痫相关的HCRU/cost没有明确的模式。结论数据显示,尽管许多PWE有准入限制,但神经科医生难以获得和主要使用第二代asm,这表明在获得治疗和专科护理方面存在障碍。
{"title":"Health care burden of access barriers to epilepsy care in the United States: A claims-based analysis of payer channels","authors":"Herbert Peeples ,&nbsp;Emily Achter ,&nbsp;Christopher Dieyi ,&nbsp;Keshia Maughn","doi":"10.1016/j.eplepsyres.2025.107639","DOIUrl":"10.1016/j.eplepsyres.2025.107639","url":null,"abstract":"<div><h3>Objective</h3><div>To describe access challenges, barriers to antiseizure medications (ASMs), and impact of ASM formulary policies for patients with epilepsy (PWE).</div></div><div><h3>Methods</h3><div>Observational study of de-identified claims from an all-payer claims database (2014–2021) and a formulary/payer policy database. Adults prescribed ≥ 1 ASM following initial epilepsy diagnosis, with continuous medical/pharmacy benefits, were included. Demographic characteristics, proximity to/use of a neurology health care professional (HCP), health care resource utilization (HCRU), and costs were assessed.</div></div><div><h3>Results</h3><div>In total, 35,351, 33,339, and 24,722 PWE with commercial, Medicare, and Medicaid insurance, respectively, were included. The Medicare group was older, had a higher comorbidity index score, more males, and fewer non-White and Hispanic individuals versus other groups. Most (&gt; 58 %) commercially-insured PWE had coverage to all six first-generation ASMs examined, six to 12 second-generation ASMs, and all four third-generation ASMs; coverage rates were higher for Medicaid while data for Medicare were incomplete. Most commercial and Medicaid PWE had no access requirements to first-generation ASMs; approximately two-thirds and half of patients had access requirements for second- and third-generation ASMs, respectively. Although &gt; 90 % of PWE used a neurology HCP during follow-up, only about one-third lived within proximity. Of PWE with formulary data (N = 77,787), &gt; 80 % and &lt; 8.0 % were prescribed second- and third-generation ASMs, respectively. There were no clear patterns in epilepsy-related HCRU/cost.</div></div><div><h3>Conclusions</h3><div>Data revealed difficulties in neurologist access and predominant use of second-generation ASMs, despite access restrictions for many PWE, suggesting obstacles in accessing treatment and specialist care.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"218 ","pages":"Article 107639"},"PeriodicalIF":2.0,"publicationDate":"2025-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144890018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceptions of health disparities among neurologists treating Black patients with epilepsy: A survey study in the United States 对治疗黑人癫痫患者的神经科医生健康差异的看法:美国的一项调查研究
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-08-05 DOI: 10.1016/j.eplepsyres.2025.107637
Ima Ebong , Pam Eads , Georgette Charles

Objective

Many factors influence patients’ experience with epilepsy, including inequities based on socially defined race and ethnicity. We sought to better understand factors contributing to health disparities in Black people living with epilepsy (PWE), as perceived by neurologists, and the value of programs to help healthcare providers (HCPs) reduce these disparities.

Methods

An online, blinded, cross-sectional survey was administered to neurologists (November 8–18, 2022) whose population of PWE included ≥ 20 % of Black individuals and who had managed ≥ 10 PWE in the last 30 days. Questions assessed recognition of health disparities in PWE and the value of HCP-focused programs to address disparities. Statistical comparisons were performed by practice setting (academic vs. community).

Results

Of 101 neurologists, 48.5 % and 51.5 % worked in academic and community settings, respectively, 2.0 % of all neurologists were Black, and 28.3 % of neurologists’ patients were Black. Situations most commonly having a major/severe negative health impact were ‘inconsistent treatment adherence/compliance’ and ‘have significant comorbidities’ in all PWE, and ‘missed appointments’ and ‘mistrust in the healthcare system’ in Black PWE. In total, 27.7 % of neurologists (42.9 % academic vs. 13.5 % community-based; p < 0.05) completely agreed that racism is a social determinant of health (SDOH). HCP-focused programs were generally considered as somewhat/very important to improve outcomes in Black PWE.

Conclusions

Fewer than a third of neurologists completely agreed that racism is an SDOH, variably suggesting no perceived differences in their patient populations (leading to disagreement) or providing evidence of implicit/unconscious bias. Increasing neurologists' participation in HCP-focused programs may help counter health disparities in Black PWE, or at a minimum improve awareness that disparities exist.
许多因素影响患者的癫痫经历,包括基于社会定义的种族和民族的不平等。我们试图更好地了解神经科医生认为黑人癫痫患者(PWE)健康差异的因素,以及帮助医疗保健提供者(HCPs)减少这些差异的项目的价值。方法对患有PWE的神经科医生(2022年11月8日至18日)进行在线、盲法、横断面调查,这些医生的PWE人群包括≥ 20% %的黑人,并且在过去30天内处理过≥ 10例PWE。评估了对PWE中健康差异的认识以及以hcp为重点的解决差异的方案的价值。通过实践环境(学术与社区)进行统计比较。结果101名神经科医生中,在学术和社区工作的分别占48.5% %和51.5% %,所有神经科医生中黑人占2.0% %,神经科医生的患者中黑人占28.3% %。最常见的对健康产生重大/严重负面影响的情况是所有PWE中“不一致的治疗依从性/依从性”和“有显著的合并症”,以及黑色PWE中“错过预约”和“对医疗系统的不信任”。总的来说,27.7% %的神经科医生(42.9% %学术vs 13. %社区;p <; 0.05)完全同意种族主义是健康的社会决定因素(SDOH)。以hcp为重点的项目通常被认为对改善黑人PWE的结果有些/非常重要。结论:不到三分之一的神经科医生完全同意种族主义是一种SDOH,这可能表明他们的患者群体没有感知到差异(导致分歧),或者提供了隐性/无意识偏见的证据。增加神经科医生参与以hcp为重点的项目可能有助于消除黑人PWE的健康差异,或者至少提高对差异存在的认识。
{"title":"Perceptions of health disparities among neurologists treating Black patients with epilepsy: A survey study in the United States","authors":"Ima Ebong ,&nbsp;Pam Eads ,&nbsp;Georgette Charles","doi":"10.1016/j.eplepsyres.2025.107637","DOIUrl":"10.1016/j.eplepsyres.2025.107637","url":null,"abstract":"<div><h3>Objective</h3><div>Many factors influence patients’ experience with epilepsy, including inequities based on socially defined race and ethnicity. We sought to better understand factors contributing to health disparities in Black people living with epilepsy (PWE), as perceived by neurologists, and the value of programs to help healthcare providers (HCPs) reduce these disparities.</div></div><div><h3>Methods</h3><div>An online, blinded, cross-sectional survey was administered to neurologists (November 8–18, 2022) whose population of PWE included ≥ 20 % of Black individuals and who had managed ≥ 10 PWE in the last 30 days. Questions assessed recognition of health disparities in PWE and the value of HCP-focused programs to address disparities. Statistical comparisons were performed by practice setting (academic vs. community).</div></div><div><h3>Results</h3><div>Of 101 neurologists, 48.5 % and 51.5 % worked in academic and community settings, respectively, 2.0 % of all neurologists were Black, and 28.3 % of neurologists’ patients were Black. Situations most commonly having a major/severe negative health impact were ‘inconsistent treatment adherence/compliance’ and ‘have significant comorbidities’ in all PWE, and ‘missed appointments’ and ‘mistrust in the healthcare system’ in Black PWE. In total, 27.7 % of neurologists (42.9 % academic vs. 13.5 % community-based; p &lt; 0.05) completely agreed that racism is a social determinant of health (SDOH). HCP-focused programs were generally considered as somewhat/very important to improve outcomes in Black PWE.</div></div><div><h3>Conclusions</h3><div>Fewer than a third of neurologists completely agreed that racism is an SDOH, variably suggesting no perceived differences in their patient populations (leading to disagreement) or providing evidence of implicit/unconscious bias. Increasing neurologists' participation in HCP-focused programs may help counter health disparities in Black PWE, or at a minimum improve awareness that disparities exist.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"218 ","pages":"Article 107637"},"PeriodicalIF":2.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144829607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interictal epileptiform discharges as the most significant confounding factor underlying memory impairment in focal epilepsy 癫痫样放电是局灶性癫痫记忆障碍最重要的混杂因素
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-07-30 DOI: 10.1016/j.eplepsyres.2025.107636
Anna Sákovics , Gábor Csukly , Csaba Borbély , Anna Kelemen , Zsófia Jordán , Boglárka Hajnal , Johanna Petra Szabó , Loránd Erőss , Dániel Fabó

Background

Cognitive disturbances are highly prevalent in focal epilepsy and are often attributed to multifactorial causes, though the specific contributions of various predictors remain poorly understood. This study aimed to identify and prioritize factors contributing to memory deficits in temporal lobe epilepsy, with a particular emphasis on interictal epileptiform discharges (IED).

Methods

In a cohort of 48 patients with temporal lobe epilepsy undergoing presurgical evaluation with invasive foramen ovale electrodes, we examined offline memory performance alongside language and attention as controls. Cognitive performance was correlated with mesial temporal IED rates recorded over 24 h and additional factors, including seizure characteristics, age at onset, epilepsy duration, temporal lobe lesions, and antiseizure medication use.

Results

A robust negative correlation emerged between mesial temporal IED rates and hippocampal-dependent cognitive scores (r = -0.43 - −0.29, p < 0.05), suggesting a direct impact of IEDs on memory consolidation processes. Epilepsy duration, antiseizure medication use and generalized seizures showed limited associations, but other variables including seizure frequency did not significantly correlate with cognitive performance.

Significance

Our findings suggest that IEDs may be the most relevant confounding factor contributing to sustained cognitive deficits in focal epilepsy. While IEDs are recognized markers of transient cognitive disruption, they have not yet demonstrated sufficient sensitivity or specificity as biomarkers of long-term cognitive dysfunction. Our study highlights the potential of IED frequency as a practical, clinically accessible biomarker for predicting chronic cognitive decline. These results emphasize the importance of developing targeted therapeutic strategies aimed at reducing interictal activity to improve cognitive outcomes.
背景:认知障碍在局灶性癫痫中非常普遍,通常归因于多因素原因,尽管各种预测因素的具体贡献仍然知之甚少。本研究旨在确定并优先考虑导致颞叶癫痫记忆缺陷的因素,特别强调间歇癫痫样放电(IED)。方法采用侵入性卵圆孔电极对48例颞叶癫痫患者进行术前评估,我们检测了离线记忆表现,并将语言和注意力作为对照。认知表现与24 h以上记录的中颞叶IED发生率以及其他因素相关,包括癫痫发作特征、发病年龄、癫痫持续时间、颞叶病变和抗癫痫药物使用。结果中颞叶IED发生率与海马依赖性认知评分呈显著负相关(r = -0.43 - - 0.29,p <; 0.05),表明IED对记忆巩固过程有直接影响。癫痫持续时间、抗癫痫药物使用和全面性癫痫发作显示出有限的关联,但包括癫痫发作频率在内的其他变量与认知表现没有显著相关性。我们的研究结果表明,ied可能是导致局灶性癫痫患者持续认知缺陷的最相关的混杂因素。虽然ied是公认的短暂性认知障碍的标志物,但作为长期认知功能障碍的生物标志物,它们尚未表现出足够的敏感性或特异性。我们的研究强调了IED频率作为预测慢性认知衰退的实用、临床可及的生物标志物的潜力。这些结果强调了开发旨在减少间歇活动以改善认知结果的靶向治疗策略的重要性。
{"title":"Interictal epileptiform discharges as the most significant confounding factor underlying memory impairment in focal epilepsy","authors":"Anna Sákovics ,&nbsp;Gábor Csukly ,&nbsp;Csaba Borbély ,&nbsp;Anna Kelemen ,&nbsp;Zsófia Jordán ,&nbsp;Boglárka Hajnal ,&nbsp;Johanna Petra Szabó ,&nbsp;Loránd Erőss ,&nbsp;Dániel Fabó","doi":"10.1016/j.eplepsyres.2025.107636","DOIUrl":"10.1016/j.eplepsyres.2025.107636","url":null,"abstract":"<div><h3>Background</h3><div>Cognitive disturbances are highly prevalent in focal epilepsy and are often attributed to multifactorial causes, though the specific contributions of various predictors remain poorly understood. This study aimed to identify and prioritize factors contributing to memory deficits in temporal lobe epilepsy, with a particular emphasis on interictal epileptiform discharges (IED).</div></div><div><h3>Methods</h3><div>In a cohort of 48 patients with temporal lobe epilepsy undergoing presurgical evaluation with invasive foramen ovale electrodes, we examined offline memory performance alongside language and attention as controls. Cognitive performance was correlated with mesial temporal IED rates recorded over 24 h and additional factors, including seizure characteristics, age at onset, epilepsy duration, temporal lobe lesions, and antiseizure medication use.</div></div><div><h3>Results</h3><div>A robust negative correlation emerged between mesial temporal IED rates and hippocampal-dependent cognitive scores (r = -0.43 - −0.29, p &lt; 0.05), suggesting a direct impact of IEDs on memory consolidation processes. Epilepsy duration, antiseizure medication use and generalized seizures showed limited associations, but other variables including seizure frequency did not significantly correlate with cognitive performance.</div></div><div><h3>Significance</h3><div>Our findings suggest that IEDs may be the most relevant confounding factor contributing to sustained cognitive deficits in focal epilepsy. While IEDs are recognized markers of transient cognitive disruption, they have not yet demonstrated sufficient sensitivity or specificity as biomarkers of long-term cognitive dysfunction. Our study highlights the potential of IED frequency as a practical, clinically accessible biomarker for predicting chronic cognitive decline. These results emphasize the importance of developing targeted therapeutic strategies aimed at reducing interictal activity to improve cognitive outcomes.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"218 ","pages":"Article 107636"},"PeriodicalIF":2.0,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144842637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Principal component analysis of antiseizure medication-induced hostility/aggression and factor analysis of levetiracetam using the food and drug administration adverse event reporting system 应用食品药品监督管理局不良事件报告系统对左乙拉西坦抗癫痫药物致敌意/攻击的主成分分析及因子分析
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-07-21 DOI: 10.1016/j.eplepsyres.2025.107626
Ryuichiro Hosoya , Kento Kitajima , Koushirou Sogawa , Daigo Ikegami , Tomoko Terajima , Hideaki Kato , Masahiko Funada , Hajime Kagaya , Yoshihiro Uesawa

Background

Epilepsy affects approximately 50 million people worldwide. Antiseizure medications (ASMs) are essential for seizure control. However, adverse psychiatric effects, particularly hostility and aggression, affect treatment adherence and the quality of life. The risk factors and mechanisms underlying these adverse effects remain unclear.

Objective

This study aimed to classify ASM-induced hostility/aggression using the Food and Drug Administration Adverse Event Reporting System (FAERS), a global pharmacovigilance database, focusing on the risk factors and onset patterns of levetiracetam-induced hostility/aggression.

Methods

The FAERS database (2004 Q1–2022 Q1) was analyzed to calculate the reporting odds ratios for ASM-induced hostility/aggression, which were classified using a principal component analysis. Levetiracetam-induced adverse effects and the associated independent risk factors were examined. Weibull distribution analysis was used to assess the time-to-onset patterns

Results

Principal component analysis identified eight ASM-induced adverse effects, including "aggression," "anger,” “homicidal ideation," and "hostility." In those taking levetiracetam aged ≥ 12 years, male sex, younger age, and specific concomitant medications were independent risk factors for levetiracetam-induced adverse effects. Levetiracetam-induced adverse effects exhibited an early failure pattern, with a median onset of 4.5 days in patients aged ≥ 12 years and 1.5 days in those < 12 years.

Conclusion

In this study, we classified ASM-induced hostility/aggression and estimated the risk factors for levetiracetam-induced adverse effects. In particular, we identified early-onset patterns and high-risk patient profiles. These findings are consistent with clinical observations and provide insight into the mechanisms underlying these adverse effects, which will contribute to proactive risk management and personalized treatment strategies.
全世界约有5000万人患有癫痫。抗癫痫药物(asm)是控制癫痫发作的必要药物。然而,不良的精神影响,特别是敌意和攻击,影响治疗依从性和生活质量。这些不良反应的风险因素和机制尚不清楚。目的利用美国食品药品监督管理局不良事件报告系统(FAERS)全球药物警戒数据库对asm诱导的敌意/攻击进行分类,重点研究左乙拉西坦诱导的敌意/攻击的危险因素和发病模式。方法分析FAERS数据库(2004年第一季度- 2022年第一季度),计算asm诱发的敌意/攻击的报告优势比,并采用主成分分析法对其进行分类。检查左乙拉西坦引起的不良反应和相关的独立危险因素。结果主成分分析确定了8种由asm引起的不良反应,包括“攻击性”、“愤怒”、“杀人意念”和“敌意”。在年龄≥ 12岁服用左乙拉西坦的患者中,男性、年龄较小和特定的伴随药物是左乙拉西坦引起不良反应的独立危险因素。左乙拉西坦引起的不良反应表现为早期失效模式,≥ 12岁患者的中位发病时间为4.5天,≥ 12岁患者的中位发病时间为1.5天。结论本研究对asm诱导的敌意/攻击行为进行了分类,并对左乙拉西坦诱导不良反应的危险因素进行了评估。特别是,我们确定了早发模式和高危患者概况。这些发现与临床观察结果一致,并为这些不良反应的机制提供了见解,这将有助于主动风险管理和个性化治疗策略。
{"title":"Principal component analysis of antiseizure medication-induced hostility/aggression and factor analysis of levetiracetam using the food and drug administration adverse event reporting system","authors":"Ryuichiro Hosoya ,&nbsp;Kento Kitajima ,&nbsp;Koushirou Sogawa ,&nbsp;Daigo Ikegami ,&nbsp;Tomoko Terajima ,&nbsp;Hideaki Kato ,&nbsp;Masahiko Funada ,&nbsp;Hajime Kagaya ,&nbsp;Yoshihiro Uesawa","doi":"10.1016/j.eplepsyres.2025.107626","DOIUrl":"10.1016/j.eplepsyres.2025.107626","url":null,"abstract":"<div><h3>Background</h3><div>Epilepsy affects approximately 50 million people worldwide. Antiseizure medications (ASMs) are essential for seizure control. However, adverse psychiatric effects, particularly hostility and aggression, affect treatment adherence and the quality of life. The risk factors and mechanisms underlying these adverse effects remain unclear.</div></div><div><h3>Objective</h3><div>This study aimed to classify ASM-induced hostility/aggression using the Food and Drug Administration Adverse Event Reporting System (FAERS), a global pharmacovigilance database, focusing on the risk factors and onset patterns of levetiracetam-induced hostility/aggression.</div></div><div><h3>Methods</h3><div>The FAERS database (2004 Q1–2022 Q1) was analyzed to calculate the reporting odds ratios for ASM-induced hostility/aggression, which were classified using a principal component analysis. Levetiracetam-induced adverse effects and the associated independent risk factors were examined. Weibull distribution analysis was used to assess the time-to-onset patterns</div></div><div><h3>Results</h3><div>Principal component analysis identified eight ASM-induced adverse effects, including \"aggression,\" \"anger,” “homicidal ideation,\" and \"hostility.\" In those taking levetiracetam aged ≥ 12 years, male sex, younger age, and specific concomitant medications were independent risk factors for levetiracetam-induced adverse effects. Levetiracetam-induced adverse effects exhibited an early failure pattern, with a median onset of 4.5 days in patients aged ≥ 12 years and 1.5 days in those &lt; 12 years.</div></div><div><h3>Conclusion</h3><div>In this study, we classified ASM-induced hostility/aggression and estimated the risk factors for levetiracetam-induced adverse effects. In particular, we identified early-onset patterns and high-risk patient profiles. These findings are consistent with clinical observations and provide insight into the mechanisms underlying these adverse effects, which will contribute to proactive risk management and personalized treatment strategies.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"218 ","pages":"Article 107626"},"PeriodicalIF":2.0,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144679882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of in-vivo GABA+ and Glutamate levels in patients with drug resistant unilateral temporal lobe epilepsy using MEGA-PRESS and correlates with clinical semiology 应用MEGA-PRESS研究耐药单侧颞叶癫痫患者体内GABA+和谷氨酸水平及其与临床符号学的相关性
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-07-16 DOI: 10.1016/j.eplepsyres.2025.107625
N. Pradhan , Manoj Kumar , M. Sandhya , P. Bairwa , PV Prathyusha , K. Raghavendra , LG Viswanathan , A. Asranna , RC Mundlamuri , DK Deelchand , Jitender Saini , Rose Dawn Bharath , Sanjib Sinha

Background

In this study, we used in vivo MEGA-PRESS spectroscopy to investigate GABA and Glu levels in patients with drug-resistant unilateral temporal lobe epilepsy (TLE) and also look for correlation between neurometabolites and clinical semiology assessed by other modalities.

Materials and methods

Twenty-five patients with TLE underwent MRS data acquisition on a 3.0 T MRI. Bilateral single-voxel MEGA-PRESS data was acquired from mesial temporal lobes, and data was post-processed using MRSpa and LC-Model for computing neurometabolites concentration. Tissue segmentation from spectroscopic voxel was performed for tissue metabolite and CSF correction. Statistical analysis was performed to analyze differences in neurometabolic between affected and normal-sides and clinical correlations.

Results

GABA, Glu, NAA, Cr, and Cho neurometabolites were computed. The group-wise statistical comparison revealed a significantly reduced NAA level from the affected compared to normal-side of the hippocampus (p-value=0.039). We observed reduced GABA (p-value=0.07) values and hippocampal volume (p-value<0.001) were observed from the affected side. A significant negative correlation was noted between affected-side hippocampal volume and NAA concentration (rho=-0.497, p-value=0.05). Glu/NAA ratios from both affected (rho=-0.692, p-value=0.012) and normal-sides (rho=-0.608, p-value=0.016) of the hippocampus were negatively correlated with age. Concordance between neurometabolites with video-EEG for lateralization demonstrates correct classification percentage for GABA was 86.7 %, indicating that there is an 86.7 % chance that GABA will be able to lateralize the unaffected side as detected by VEEG.

Conclusion

A novel exploratory study demonstrates an alternation of in-vivo GABA and Glu levels and hippocampal volume. This study may provide a direction for utilizing MEGA-PRES as a presurgical tool for assessing in-vivo neurometabolic profiles and add to the knowledge of the role of GABA and Glu in epilepsy and its interplay.
在这项研究中,我们使用体内MEGA-PRESS光谱研究耐药单侧颞叶癫痫(TLE)患者的GABA和Glu水平,并寻找神经代谢物与其他方式评估的临床符会学之间的相关性。材料与方法25例TLE患者在3.0 T MRI上进行MRS数据采集。从内侧颞叶获取双侧单体素MEGA-PRESS数据,并使用MRSpa和LC-Model对数据进行后处理,计算神经代谢物浓度。从光谱体素中进行组织分割,用于组织代谢物和CSF校正。统计学分析患侧与正常侧神经代谢差异及临床相关性。结果计算gaba、Glu、NAA、Cr、Cho神经代谢物。组间统计比较显示,与正常侧海马相比,受损侧海马的NAA水平显著降低(p值=0.039)。我们观察到患侧GABA减少(p值=0.07),海马体积减少(p值<;0.001)。患侧海马体积与NAA浓度呈显著负相关(rho=-0.497, p值=0.05)。海马受累侧(rho=-0.692, p值=0.012)和正常侧(rho=-0.608, p值=0.016)的Glu/NAA比值与年龄呈负相关。神经代谢物与视频脑电图侧化的一致性表明,GABA的正确分类率为86.7 %,表明VEEG检测到的GABA能够侧化未受影响的一侧的几率为86.7 %。结论一项新的探索性研究证实了体内GABA和Glu水平与海马体积的变化。本研究可能为利用MEGA-PRES作为术前评估体内神经代谢谱的工具提供方向,并增加对GABA和Glu在癫痫中的作用及其相互作用的认识。
{"title":"Investigation of in-vivo GABA+ and Glutamate levels in patients with drug resistant unilateral temporal lobe epilepsy using MEGA-PRESS and correlates with clinical semiology","authors":"N. Pradhan ,&nbsp;Manoj Kumar ,&nbsp;M. Sandhya ,&nbsp;P. Bairwa ,&nbsp;PV Prathyusha ,&nbsp;K. Raghavendra ,&nbsp;LG Viswanathan ,&nbsp;A. Asranna ,&nbsp;RC Mundlamuri ,&nbsp;DK Deelchand ,&nbsp;Jitender Saini ,&nbsp;Rose Dawn Bharath ,&nbsp;Sanjib Sinha","doi":"10.1016/j.eplepsyres.2025.107625","DOIUrl":"10.1016/j.eplepsyres.2025.107625","url":null,"abstract":"<div><h3>Background</h3><div>In this study, we used in vivo MEGA-PRESS spectroscopy to investigate GABA and Glu levels in patients with drug-resistant unilateral temporal lobe epilepsy (TLE) and also look for correlation between neurometabolites and clinical semiology assessed by other modalities.</div></div><div><h3>Materials and methods</h3><div>Twenty-five patients with TLE underwent MRS data acquisition on a 3.0 T MRI. Bilateral single-voxel MEGA-PRESS data was acquired from mesial temporal lobes, and data was post-processed using MRSpa and LC-Model for computing neurometabolites concentration. Tissue segmentation from spectroscopic voxel was performed for tissue metabolite and CSF correction. Statistical analysis was performed to analyze differences in neurometabolic between affected and normal-sides and clinical correlations.</div></div><div><h3>Results</h3><div>GABA, Glu, NAA, Cr, and Cho neurometabolites were computed. The group-wise statistical comparison revealed a significantly reduced NAA level from the affected compared to normal-side of the hippocampus (p-value=0.039). We observed reduced GABA (p-value=0.07) values and hippocampal volume (p-value&lt;0.001) were observed from the affected side. A significant negative correlation was noted between affected-side hippocampal volume and NAA concentration (rho=-0.497, p-value=0.05). Glu/NAA ratios from both affected (rho=-0.692, p-value=0.012) and normal-sides (rho=-0.608, p-value=0.016) of the hippocampus were negatively correlated with age. Concordance between neurometabolites with video-EEG for lateralization demonstrates correct classification percentage for GABA was 86.7 %, indicating that there is an 86.7 % chance that GABA will be able to lateralize the unaffected side as detected by VEEG.</div></div><div><h3>Conclusion</h3><div>A novel exploratory study demonstrates an alternation of <em>in-vivo</em> GABA and Glu levels and hippocampal volume. This study may provide a direction for utilizing MEGA-PRES as a presurgical tool for assessing <em>in-vivo</em> neurometabolic profiles and add to the knowledge of the role of GABA and Glu in epilepsy and its interplay.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"218 ","pages":"Article 107625"},"PeriodicalIF":2.0,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144739530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and tolerability of magnesium sulfate in children with infantile epileptic spasms syndrome: A systematic review and meta-analysis 硫酸镁治疗小儿癫痫痉挛综合征的疗效和耐受性:系统回顾和荟萃分析
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-07-15 DOI: 10.1016/j.eplepsyres.2025.107628
Indar Kumar Sharawat , Ananthanarayanan Kasinathan , Pragnya Panda , Lesa Dawman , Juhi Tiwari , RC Pavan Kumar , Prateek Kumar Panda

Background

Several trials and clinical studies have explored the efficacy and safety of magnesium sulfate (MgSO₄) in children with infantile epileptic spasms syndrome (IESS). However, no systematic review has been conducted to synthesize the available evidence.

Methods

This systematic review aimed to assess the efficacy and safety of MgSO₄ in children with IESS. The primary outcomes included the proportion of patients achieving spasm freedom, a favorable response in the number of spasms (defined as at least a 50 % reduction in daily spasms), resolution of hypsarrhythmia, improvement in developmental quotient, and the nature and frequency of adverse events. Additionally, we compared these variables between the ACTH+MgSO₄ combination therapy and ACTH monotherapy at various time points. We included all controlled and uncontrolled trials, as well as prospective and retrospective cohort studies.

Results

A total of four studies involving 1334 IESS patients were identified. The proportion of patients achieving a favorable response in daily spasm frequency, spasm freedom, hypsarrhythmia resolution, and EEG normalization was higher in the adrenocorticotropic hormone (ACTH)+MgSO₄ group than in the ACTH monotherapy group (RR=1.22, 95 % CI: 1.09–1.36, I²=0 %, p = 0.0004; RR=1.44, 95 % CI: 1.24–1.67, I²=29 %, p < 0.00001; RR=1.27, 95 % CI: 1.15–1.41, I²=0 %, p < 0.00001; and RR=1.46, 95 % CI: 1.06–2.02, I²=0 %, p = 0.02, respectively). The proportion of patients experiencing treatment-emergent adverse events and serious adverse events was comparable between the ACTH+MgSO₄ and ACTH monotherapy groups (RR=0.55, 95 % CI: 0.28–1.07, I²=49 %, p = 0.08; and RR=1.15, 95 % CI: 0.74–1.79, I²=0 %, p = 0.54, respectively). However, the frequency of hypertension was significantly lower in the ACTH+MgSO₄ group compared to the ACTH monotherapy group (RR=0.11, 95 % CI: 0.03–0.34, I²=0 %, p = 0.0002).

Conclusions

The combination of ACTH and MgSO₄ is more effective than ACTH monotherapy in achieving seizure control in children with IESS. Additionally, it is associated with a reduced risk of certain adverse events, such as hypertension.
几项试验和临床研究探讨了硫酸镁(MgSO₄)治疗婴儿癫痫痉挛综合征(IESS)的有效性和安全性。然而,还没有进行系统的评价来综合现有的证据。方法本系统评价旨在评价硫酸镁治疗IESS患儿的有效性和安全性。主要结局包括实现痉挛自由的患者比例、痉挛次数的良好反应(定义为每日痉挛减少至少50% %)、低心律失常的缓解、发育商的改善以及不良事件的性质和频率。此外,我们比较了不同时间点ACTH+ mgso4联合治疗和ACTH单药治疗之间的这些变量。我们纳入了所有的对照和非对照试验,以及前瞻性和回顾性队列研究。结果共纳入4项研究,1334例IESS患者。促肾上腺皮质激素(ACTH)+MgSO₄组在每日痉挛频率、痉挛自由度、心律失常缓解和脑电图正常化方面取得良好反应的患者比例高于ACTH单药治疗组(RR=1.22, 95 % CI: 1.09-1.36, I²=0 %,p = 0.0004;RR = 1.44, 95 % CI: 1.24 - -1.67,我²= 29 % p & lt; 0.00001;RR = 1.27, 95 % CI: 1.15 - -1.41,我²= 0 % p & lt; 0.00001;和RR = 1.46, 95 % CI: 1.06 - -2.02,我²= 0 %,分别为p = 0.02)。发生治疗后出现的不良事件和严重不良事件的患者比例在ACTH+MgSO₄和ACTH单药治疗组之间具有可比性(RR=0.55, 95 % CI: 0.28-1.07, I²=49 %,p = 0.08;和RR = 1.15, 95 % CI: 0.74 - -1.79,我²= 0 %,分别为p = 0.54)。然而,与ACTH单药组相比,ACTH+MgSO₄组高血压发生率明显降低(RR=0.11, 95 % CI: 0.03-0.34, I²=0 %,p = 0.0002)。结论ACTH联合硫酸镁治疗对IESS患儿癫痫发作的控制效果优于单药治疗。此外,它还与某些不良事件(如高血压)的风险降低有关。
{"title":"Efficacy and tolerability of magnesium sulfate in children with infantile epileptic spasms syndrome: A systematic review and meta-analysis","authors":"Indar Kumar Sharawat ,&nbsp;Ananthanarayanan Kasinathan ,&nbsp;Pragnya Panda ,&nbsp;Lesa Dawman ,&nbsp;Juhi Tiwari ,&nbsp;RC Pavan Kumar ,&nbsp;Prateek Kumar Panda","doi":"10.1016/j.eplepsyres.2025.107628","DOIUrl":"10.1016/j.eplepsyres.2025.107628","url":null,"abstract":"<div><h3>Background</h3><div>Several trials and clinical studies have explored the efficacy and safety of magnesium sulfate (MgSO₄) in children with infantile epileptic spasms syndrome (IESS). However, no systematic review has been conducted to synthesize the available evidence.</div></div><div><h3>Methods</h3><div>This systematic review aimed to assess the efficacy and safety of MgSO₄ in children with IESS. The primary outcomes included the proportion of patients achieving spasm freedom, a favorable response in the number of spasms (defined as at least a 50 % reduction in daily spasms), resolution of hypsarrhythmia, improvement in developmental quotient, and the nature and frequency of adverse events. Additionally, we compared these variables between the ACTH+MgSO₄ combination therapy and ACTH monotherapy at various time points. We included all controlled and uncontrolled trials, as well as prospective and retrospective cohort studies.</div></div><div><h3>Results</h3><div>A total of four studies involving 1334 IESS patients were identified. The proportion of patients achieving a favorable response in daily spasm frequency, spasm freedom, hypsarrhythmia resolution, and EEG normalization was higher in the adrenocorticotropic hormone (ACTH)+MgSO₄ group than in the ACTH monotherapy group (RR=1.22, 95 % CI: 1.09–1.36, I²=0 %, p = 0.0004; RR=1.44, 95 % CI: 1.24–1.67, I²=29 %, p &lt; 0.00001; RR=1.27, 95 % CI: 1.15–1.41, I²=0 %, p &lt; 0.00001; and RR=1.46, 95 % CI: 1.06–2.02, I²=0 %, p = 0.02, respectively). The proportion of patients experiencing treatment-emergent adverse events and serious adverse events was comparable between the ACTH+MgSO₄ and ACTH monotherapy groups (RR=0.55, 95 % CI: 0.28–1.07, I²=49 %, p = 0.08; and RR=1.15, 95 % CI: 0.74–1.79, I²=0 %, p = 0.54, respectively). However, the frequency of hypertension was significantly lower in the ACTH+MgSO₄ group compared to the ACTH monotherapy group (RR=0.11, 95 % CI: 0.03–0.34, I²=0 %, p = 0.0002).</div></div><div><h3>Conclusions</h3><div>The combination of ACTH and MgSO₄ is more effective than ACTH monotherapy in achieving seizure control in children with IESS. Additionally, it is associated with a reduced risk of certain adverse events, such as hypertension.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"217 ","pages":"Article 107628"},"PeriodicalIF":2.0,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144653410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depressive symptoms in Chinese patients with epilepsy: Prevalence and clinical correlates 中国癫痫患者抑郁症状:患病率及临床相关性
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-07-14 DOI: 10.1016/j.eplepsyres.2025.107624
Yuwei Han , Shun Gong , Shimei Sun, Dan Yang, Bingying Zhang, Dandan Gao, Guanqian Yuan, Xiaoming Li, Guangzhi Hao, Guobiao Liang

Objective

Depressive symptoms were a prevalent comorbidity among patients with epilepsy, significantly impacting their quality of life and treatment outcomes. This study aims to investigate the prevalence and clinical correlates of depressive symptoms in Chinese patients with epilepsy.

Methods

A descriptive cross-sectional study was conducted at the Department of Neurosurgery, General Hospital of Northern Theater Command, from January 2018 to June 2023. Patients diagnosed with epilepsy aged 16 years or older were included, excluding those with severe illnesses, substance abuse disorders, or severe cognitive impairments. Demographic and epilepsy-related information was collected using a standardized clinical data collection form. Depressive symptoms were assessed using the Beck Depression Inventory-II (BDI-II). Statistical analyses were performed using SPSS version 27.0.

Results

The study included 513 patients with epilepsy, with a mean age of 37.48 years (SD= 15.09). Among these, 65.9 % were male, and 62.6 % were aged 40 years or older. The majority of patients were single (50.9 %) and had formal education (57.1 %). The mean age of epilepsy onset was 21.96 years (SD = 12.83), and the mean duration of illness was 11.02 years (SD= 13.64). Generalized tonic-clonic seizures were the most common type (62.0 %), and 32.7 % of patients experienced very frequent seizures. Polytherapy was used by 63.5 % of patients. Depressive symptoms were present in 137 patients, representing a prevalence of 26.7 % (95 % CI: 20.51–31.89). The severity of depressive symptoms was categorized as mild in 62.0 %, mild to moderate in 18.2 %, moderate in 10.2 %, and severe in 9.5 %. The prevalence of depressive symptoms was higher among females, separated/widowed individuals, those with lower educational attainment, and unemployed patients. Significant associations were found between depressive symptoms and seizure frequency, duration of seizures, and polytherapy. Multivariate analysis identified seizure frequency, duration of seizures, and polytherapy as independent predictors of depressive symptoms.

Conclusions

Depressive symptoms were highly prevalent among Chinese patients with epilepsy, with significant associations found between depressive symptoms and several sociodemographic and clinical characteristics. Routine screening for depressive symptoms and tailored interventions are crucial for improving the quality of life and treatment outcomes in this population. Future research should focus on longitudinal studies to explore causal relationships and develop targeted interventions.
目的:抑郁症状是癫痫患者常见的合并症,显著影响癫痫患者的生活质量和治疗效果。本研究旨在探讨中国癫痫患者抑郁症状的患病率及临床相关因素。方法于2018年1月至2023年6月在北方战区总医院神经外科进行描述性横断面研究。16岁及以上的癫痫患者被纳入研究,但不包括那些患有严重疾病、药物滥用障碍或严重认知障碍的患者。使用标准化的临床数据收集表收集人口统计学和癫痫相关信息。使用贝克抑郁量表- ii (BDI-II)评估抑郁症状。采用SPSS 27.0进行统计分析。结果纳入513例癫痫患者,平均年龄37.48岁(SD= 15.09)。其中男性占65.9% %,年龄在40岁以上的占62.6 %。大多数患者为单身(50.9 %)和受过正规教育(57.1% %)。平均发病年龄21.96岁(SD= 12.83),平均发病时间11.02岁(SD= 13.64)。全身性强直-阵挛性发作是最常见的类型(62.0 %),32.7% %的患者经历过非常频繁的发作。63.5% %的患者采用综合治疗。137例患者出现抑郁症状,患病率为26.7 %(95 % CI: 20.51-31.89)。抑郁症状的严重程度分为轻度(62.0 %)、轻度至中度(18.2% %)、中度(10. %)和重度(9.5% %)。抑郁症状的患病率在女性、分居/丧偶个体、受教育程度较低的个体和失业患者中较高。发现抑郁症状与发作频率、发作持续时间和多种治疗之间存在显著关联。多变量分析确定癫痫发作频率、癫痫发作持续时间和多种治疗是抑郁症状的独立预测因子。结论抑郁症状在中国癫痫患者中非常普遍,抑郁症状与一些社会人口学和临床特征有显著相关性。常规抑郁症状筛查和量身定制的干预措施对于改善这一人群的生活质量和治疗效果至关重要。未来的研究应侧重于纵向研究,以探索因果关系并制定有针对性的干预措施。
{"title":"Depressive symptoms in Chinese patients with epilepsy: Prevalence and clinical correlates","authors":"Yuwei Han ,&nbsp;Shun Gong ,&nbsp;Shimei Sun,&nbsp;Dan Yang,&nbsp;Bingying Zhang,&nbsp;Dandan Gao,&nbsp;Guanqian Yuan,&nbsp;Xiaoming Li,&nbsp;Guangzhi Hao,&nbsp;Guobiao Liang","doi":"10.1016/j.eplepsyres.2025.107624","DOIUrl":"10.1016/j.eplepsyres.2025.107624","url":null,"abstract":"<div><h3>Objective</h3><div>Depressive symptoms were a prevalent comorbidity among patients with epilepsy, significantly impacting their quality of life and treatment outcomes. This study aims to investigate the prevalence and clinical correlates of depressive symptoms in Chinese patients with epilepsy.</div></div><div><h3>Methods</h3><div>A descriptive cross-sectional study was conducted at the Department of Neurosurgery, General Hospital of Northern Theater Command, from January 2018 to June 2023. Patients diagnosed with epilepsy aged 16 years or older were included, excluding those with severe illnesses, substance abuse disorders, or severe cognitive impairments. Demographic and epilepsy-related information was collected using a standardized clinical data collection form. Depressive symptoms were assessed using the Beck Depression Inventory-II (BDI-II). Statistical analyses were performed using SPSS version 27.0.</div></div><div><h3>Results</h3><div>The study included 513 patients with epilepsy, with a mean age of 37.48 years (SD= 15.09). Among these, 65.9 % were male, and 62.6 % were aged 40 years or older. The majority of patients were single (50.9 %) and had formal education (57.1 %). The mean age of epilepsy onset was 21.96 years (SD = 12.83), and the mean duration of illness was 11.02 years (SD= 13.64). Generalized tonic-clonic seizures were the most common type (62.0 %), and 32.7 % of patients experienced very frequent seizures. Polytherapy was used by 63.5 % of patients. Depressive symptoms were present in 137 patients, representing a prevalence of 26.7 % (95 % CI: 20.51–31.89). The severity of depressive symptoms was categorized as mild in 62.0 %, mild to moderate in 18.2 %, moderate in 10.2 %, and severe in 9.5 %. The prevalence of depressive symptoms was higher among females, separated/widowed individuals, those with lower educational attainment, and unemployed patients. Significant associations were found between depressive symptoms and seizure frequency, duration of seizures, and polytherapy. Multivariate analysis identified seizure frequency, duration of seizures, and polytherapy as independent predictors of depressive symptoms.</div></div><div><h3>Conclusions</h3><div>Depressive symptoms were highly prevalent among Chinese patients with epilepsy, with significant associations found between depressive symptoms and several sociodemographic and clinical characteristics. Routine screening for depressive symptoms and tailored interventions are crucial for improving the quality of life and treatment outcomes in this population. Future research should focus on longitudinal studies to explore causal relationships and develop targeted interventions.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"217 ","pages":"Article 107624"},"PeriodicalIF":2.0,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144653411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
White matter integrity and its correlation to seizures in diffuse glioma 弥漫性胶质瘤中白质完整性及其与癫痫发作的关系
IF 2 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-07-14 DOI: 10.1016/j.eplepsyres.2025.107627
Ludwig Klein , Gordian Prasse , Alim E. Basaran , Jost-Julian Rumpf , Martin Vychopen , Johannes Wach , Erdem Güresir , Tim Wende

Introduction

Seizures are one of the most common symptoms in patients with diffuse glioma, occurring in 30–80 % of cases. Although seizure control can be achieved in up to 90 %, seizures remain a significant burden and are hardly predictable. The aim of this analysis was, therefore, to investigate the association between white matter integrity and seizure occurrence in patients with diffuse glioma using diffusion tensor imaging (DTI).

Methods

Patients with first diagnosis of diffuse glioma (WHO-grade 2, 3, 4) who received preoperative DTI sequences for surgical planning were analyzed. Tractography of corpus callosum and cingulum was carried out, extracting mean FA values of the resulting volumes.

Results

50 patients (17 female) were included with a mean age of 59.5 ± 2.2 years. Glioma WHO grade 4 was most common (82 %), followed by grade 3 (10 %) and grade 2 (8 %). Most gliomas were located left temporal (32 %) and bilateral frontal (each hemisphere 16 %). 16 % presented with multifocal glioma. 48 % had suffered seizures prior to surgery, and were thus diagnosed with structural epilepsy. 22 % of all patients presented recurring seizures despite surgery and anti-seizure medication, and 6 % developed new seizures after surgery. After correction for multiple comparisons, increased FA in the left parahippocampal cingulum was significantly associated with preoperative seizures (0.30 ± 0.01 versus 0.27 ± 0.01, pcorr = 0.007), while increased FA in the forceps minor of the corpus callosum correlated with postoperative seizures (0.49 ± 0.01 versus 0.43 ± 0.01, pcorr = 0.014).

Conclusion

Higher preoperative white matter integrity was associated with increased risk for occurrence of seizures in diffuse glioma. Further research is warranted to investigate the relation with tumor pathology.
癫痫发作是弥漫性胶质瘤患者最常见的症状之一,发生率为30 - 80% %。虽然癫痫发作控制可以达到90% %,但癫痫发作仍然是一个重大负担,很难预测。因此,本分析的目的是利用弥散张量成像(DTI)研究弥漫性胶质瘤患者白质完整性与癫痫发作之间的关系。方法对首次诊断为弥漫性胶质瘤(who分级2级、3级、4级)且术前接受DTI序列进行手术计划的患者进行分析。对胼胝体和扣带进行神经束造影,提取所得体积的平均FA值。结果纳入50例患者,其中女性17例,平均年龄59.5 ± 2.2岁。WHO 4级胶质瘤最常见(82% %),其次是3级(10 %)和2级(8 %)。大多数胶质瘤位于左侧颞叶(32 %)和双侧额叶(每个半球16 %)。16% %为多灶性胶质瘤。48% %手术前曾有癫痫发作,因此被诊断为结构性癫痫。22 %的患者在手术和抗癫痫药物治疗后出现复发性癫痫发作,6 %的患者在手术后出现新的癫痫发作。经多次校正比较,左侧海马旁扣带FA增加与术前癫痫发作显著相关(0.30 ± 0.01 vs 0.27 ± 0.01,pcorr = 0.007),胼胝体小钳FA增加与术后癫痫发作相关(0.49 ± 0.01 vs 0.43 ± 0.01,pcorr = 0.014)。结论弥漫性胶质瘤患者术前白质完整性增高与癫痫发作风险增加相关。值得进一步研究其与肿瘤病理的关系。
{"title":"White matter integrity and its correlation to seizures in diffuse glioma","authors":"Ludwig Klein ,&nbsp;Gordian Prasse ,&nbsp;Alim E. Basaran ,&nbsp;Jost-Julian Rumpf ,&nbsp;Martin Vychopen ,&nbsp;Johannes Wach ,&nbsp;Erdem Güresir ,&nbsp;Tim Wende","doi":"10.1016/j.eplepsyres.2025.107627","DOIUrl":"10.1016/j.eplepsyres.2025.107627","url":null,"abstract":"<div><h3>Introduction</h3><div>Seizures are one of the most common symptoms in patients with diffuse glioma, occurring in 30–80 % of cases. Although seizure control can be achieved in up to 90 %, seizures remain a significant burden and are hardly predictable. The aim of this analysis was, therefore, to investigate the association between white matter integrity and seizure occurrence in patients with diffuse glioma using diffusion tensor imaging (DTI).</div></div><div><h3>Methods</h3><div>Patients with first diagnosis of diffuse glioma (WHO-grade 2, 3, 4) who received preoperative DTI sequences for surgical planning were analyzed. Tractography of corpus callosum and cingulum was carried out, extracting mean FA values of the resulting volumes.</div></div><div><h3>Results</h3><div>50 patients (17 female) were included with a mean age of 59.5 ± 2.2 years. Glioma WHO grade 4 was most common (82 %), followed by grade 3 (10 %) and grade 2 (8 %). Most gliomas were located left temporal (32 %) and bilateral frontal (each hemisphere 16 %). 16 % presented with multifocal glioma. 48 % had suffered seizures prior to surgery, and were thus diagnosed with structural epilepsy. 22 % of all patients presented recurring seizures despite surgery and anti-seizure medication, and 6 % developed new seizures after surgery. After correction for multiple comparisons, increased FA in the left parahippocampal cingulum was significantly associated with preoperative seizures (0.30 ± 0.01 versus 0.27 ± 0.01, p<sub>corr</sub> = 0.007), while increased FA in the forceps minor of the corpus callosum correlated with postoperative seizures (0.49 ± 0.01 versus 0.43 ± 0.01, p<sub>corr</sub> = 0.014).</div></div><div><h3>Conclusion</h3><div>Higher preoperative white matter integrity was associated with increased risk for occurrence of seizures in diffuse glioma. Further research is warranted to investigate the relation with tumor pathology.</div></div>","PeriodicalId":11914,"journal":{"name":"Epilepsy Research","volume":"217 ","pages":"Article 107627"},"PeriodicalIF":2.0,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144632069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Epilepsy Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1